Journals / El-Cezeri / 2022 / Cilt: 9 - Sayı: 2

Synthesis, Crystallographic Structure, Spectral (FT-IR, UV) Properties, Hirshfeld Surface Analysis and Molecular Docking Studies of a New Cobalt-(II) Complex with Diclofenac Including Nitrogen Donor Ligands

Nitrojen Donör Ligantları İçeren Diklofenaklı yeni bir Kobalt-(II) Kompleksinin Sentez, Kristalografik Yapı, Spektral (FT-IR, UV) Özellikleri, Hirshfeld Yüzey Analizi ve Moleküler Kenetlenme Çalışmaları

Journal
El-Cezeri
Pages
695–707
Publication Date
2022-05-31
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Finally, molecular docking studies with different two receptors (5U9D and 4XTA) have been performed to show whether the title molecule has anti-tumor and anti-inflammatory activity, respectively.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:The new diclofenac-based cobalt (II) complex, namely bis {2- [2-(2,6-dichloro anilino) phenyl] acetato-κ'O, O'} bis (2-methyl-1H-imidazole-κN3cobalt (II) has been synthesized and characterized by FT–IR, UV spectroscopies and single crystal X-ray diffraction techniques.
📊
Key Findings & Data:The title complex crystallizes in the monoclinic space group I2/a with a = 19.0546(8) Å, b = 13.7167(8) Å, c = 14.7165(7) Å, a = 90˚, b = 13.7167(8) Å and g = 90˚ and Z=4.
💡
Conclusion & Impact:Finally, molecular docking studies with different two receptors (5U9D and 4XTA) have been performed to show whether the title molecule has anti-tumor and anti-inflammatory activity, respectively.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Kobalt (II) · Diklofenak · Kristal yapı

Abstract

The new diclofenac-based cobalt (II) complex, namely bis {2- [2-(2,6-dichloro anilino) phenyl] acetato-κ'O, O'} bis (2-methyl-1H-imidazole-κN3cobalt (II) has been synthesized and characterized by FT–IR, UV spectroscopies and single crystal X-ray diffraction techniques. The title complex crystallizes in the monoclinic space group I2/a with a = 19.0546(8) Å, b = 13.7167(8) Å, c = 14.7165(7) Å, a = 90˚, b = 13.7167(8) Å and g = 90˚ and Z=4. According to the X-ray diffraction technique results, the cobalt ion is coordinated to diclofenac and methyl imidazole ligands and the title complex adopts a distorted tetrahedral geometry with τ_4^' = 0.75. The monomer is linked by conventional C–H···O and C–H···N intermolecular hydrogen bonds as well as C–H···π interactions to form sheet structures in 3D space. Additionally, the intermolecular interactions in the title complex have examined using Hirshfeld surface analysis technique. The major interactions of the complex are H···H (46%), H···Cl (21%), C···H (17.2%) and O···H (7.6%). Finally, molecular docking studies with different two receptors (5U9D and 4XTA) have been performed to show whether the title molecule has anti-tumor and anti-inflammatory activity, respectively.

Özet

Yeni diklofenak bazlı cobalt (II) kompleksi, bis {2- [2-(2,6-dikloro anilino) fenil] asetato-κ'O, O'} bis (2-metil-1H-imidazol-κN3cobalt (II) sentezlenmiş ve FT-IR, UV spektroskopileri ve tek kristal X-ışını kırınımı ile karakterize edilmiştir. Başlık kompleksi I2/a momoklinik uzay grubunda a = 19.0546(8) Å, b = 13.7167(8) Å, c = 14.7165(7) Å, a = 90˚, b = 13.7167(8) Å ve g = 90˚ ve Z=4 ile kristalleşir. X-ışını kırınım tekniğine göre, kobalt iyonu diklofenak ve metil imidazol ligandlarına koordinedir ve başlık kompleksi τ_4^' = 0.75 ile çarpık bir tetrahedral formu benimsemektedir. Monomer, 3-boyutlu uzayda tabaka yapıları oluşturmak için C–H···π etkileşimlerinin yanı sıra moleküller arası geleneksel C–H···O and C–H···N hidrojen bağları yoluyla bağlanır. Ek olarak başlık kompleksindeki moleküller arası etkileşimler Hirshfeld yüzey analizi tekniği kullanılarak incelenmiştir. Kompleksin başlıca etkileşimleri, H···H (46%), H···Cl (21%), C···H (17.2%) ve O···H (7.6%) dır. Son olarak başlık molekülünün sırasıyla, anti-tümör ve anti-inflamatuar aktiviteye sahip olup olmadığını göstermek için iki farklı reseptör (5U9D ve 4XTA) ile moleküler kenetlenme çalışmaları yapılmıştır.

🔖

Cite This Article

UZUN, S. (2022). Synthesis, Crystallographic Structure, Spectral (FT-IR, UV) Properties, Hirshfeld Surface Analysis and Molecular Docking Studies of a New Cobalt-(II) Complex with Diclofenac Including Nitrogen Donor Ligands. El-Cezeri, Cilt: 9 - Sayı: 2, 695–707. https://ajindex.com/articles/662610

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (1)

  1. . Fan, X., Dong, J., Min, R., Chen, Y., Yi, X., Zhou, J., & Zhang, S, “Cobalt (II) complexes with thiosemicarbazone as potential antitumor agents: synthesis, crystal structures, DNA interactions, and cytotoxicity”, Journal of Coordination Chemistry, 2013, 66(24): 4268–4279. [2]. Ali, H. A., Shamma, A. A., & Kamel, S, “New mixed ligand cobalt (II/III) complexes based on the drug sodium valproate and bioactive nitrogen-donor ligands. Synthesis, structure and biological properties”, Journal of Molecular Structure, 2017, 1142: 40–47. [3]. Heffern, M. C., Velasco, P. T., Matosziuk, L. M., Coomes, J. L., Karras, C., Ratner, M. A.,. & Meade, T. J, “Modulation of amyloid-β aggregation by histidine-coordinating Cobalt (III) Schiff base complexes”, Chembiochem: a European journal of chemical biology, 2014, 15(11): 1584. [4]. Lopez-Sandoval, H., Londono-Lemos, M. E., Garza-Velasco, R., Poblano-Meléndez, I., Granada-Macías, P., Gracia-Mora, I., & Barba-Behrens, N, “Synthesis, structure and biological activities of cobalt (II) and zinc (II) coordination compounds with 2-benzimidazole derivatives”, Journal of Inorganic Biochemistry, 2008, 102(5-6): 1267–1276. [5]. Ott, I., Abraham, A., Schumacher, P., Shorafa, H., Gastl, G., Gust, R., & Kircher, B, “Synergistic and additive antiproliferative effects on human leukemia cell lines induced by combining acetylenehexacarbonyldicobalt complexes with the tyrosine kinase inhibitor imatinib”, Journal of inorganic biochemistry, 2006, 100(11): 1903–1906. [6]. Miodragović, D. U., Bogdanović, G. A., Miodragović, Z. M., Radulović, M. Đ., Novaković, S. B., Kaluđerović, G. N., & Kozłowski, H, “Interesting coordination abilities of antiulcer drug famotidine and antimicrobial activity of drug and its cobalt (III) complex”, Journal of inorganic biochemistry, 2006, 100(9): 1568–1574. [7]. Nomiya, K., Yoshizawa, A., Tsukagoshi, K., Kasuga, N. C., Hirakawa, S., & Watanabe, J, “ Synthesis and structural characterization of silver (I), aluminium (III) and cobalt (II) complexes with 4-isopropyltropolone (hinokitiol) showing noteworthy biological activities. Action of silver (I)-oxygen bonding complexes on the antimicrobial activities”, Journal of inorganic biochemistry, 2004, 98(1): 46–60. [8]. Lv, J., Liu, T., Cai, S., Wang, X., Liu, L., & Wang, Y, “Synthesis, structure and biological activity of cobalt (II) and copper (II) complexes of valine-derived schiff bases”, Journal of Inorganic Biochemistry, 2006, 100(11): 1888–1896. [9]. Böt